Inspira Technologies announced that its INSPIRA ART100 system has completed clinical evaluation at a top U.S. academic medical center, leading to a budgeted procurement process. The system treated 30 patients across various medical indications, moving from pilot use to standard clinical workflow. The medical center has initiated an internal procurement process for multiple ART100 systems, signaling a strong validation of the technology’s clinical value. This milestone strengthens the company’s U.S. commercial positioning and supports broader adoption of the ART100 platform in healthcare institutions. For more information, visit: https://inspira-technologies.com.

Read more at GlobeNewswire: ART100 Becomes Inspira’s First System to Complete Clinical